tiprankstipranks
Trending News
More News >
Autolus Therapeutics Plc (AUTL)
NASDAQ:AUTL
US Market

Autolus Therapeutics (AUTL) Income Statement

Compare
639 Followers

Autolus Therapeutics Income Statement

Last quarter (Q4 2024), Autolus Therapeutics's total revenue was $29.00K, a decrease of -98.37% from the same quarter last year. In Q4, Autolus Therapeutics's net income was $-27.61M. See Autolus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 10.12M$ 1.70M$ 6.19M$ 2.33M$ 242.00K
Gross Profit
$ -1.27M$ -4.87M$ -131.03M$ -126.32M$ -134.65M
Operating Expenses
$ 240.16M$ 1.70M$ 173.72M$ 166.65M$ 168.39M
Depreciation and Amortization
$ 7.72M$ 6.57M$ 7.42M$ 8.55M$ 5.75M
EBITDA
$ -202.12M$ -156.77M$ -135.54M$ -132.01M$ -160.51M
Operating Income
$ -241.43M$ -195.03M$ -163.78M$ -164.21M$ -168.15M
Other Income/Expenses
$ 22.29M$ -13.37M$ -9.42M$ 109.22M$ 1.89M
Pretax Income
$ -219.13M$ -208.40M$ -173.21M$ -165.99M$ -166.26M
Net Income
$ -220.66M$ -208.38M$ -148.84M$ -142.10M$ -142.09M
Per Share Metrics
Basic EPS
$ -0.86$ -1.20$ -1.57$ -1.97$ -2.76
Diluted EPS
$ -0.86$ -1.20$ -1.57$ -1.97$ -2.76
Weighted Average Shares Outstanding
255.16M 173.94M 94.99M 72.08M 51.56M
Weighted Average Shares Outstanding (Diluted)
255.16M 173.94M 94.99M 72.08M 51.56M
Currency in USD

Autolus Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis